| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.37 | 0.01 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.006 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.32 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.24 | 0.2 |